Glenmark shares gain; Oct-Dec earnings beat forecasts

Reuters Market Eye - Shares of Glenmark Pharmaceuticals surge 5 percent after the company reported better-than-expected earnings.

Glenmark Pharma reported a consolidated net profit of 2.16 billion rupees in the October-December quarter, compared with the mean consensus forecasts of 1.81 billion rupees, compiled by Thomson Reuters StarMine.

(Reporting by Dipika Lalwani)